Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Howard

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
Journal of Aerosol Science|May 16, 2024
Evaluation of methods for characterizing the fine particulate matter emissions from aircraft and other diffusion flame combustion aerosol sourcesRobert Giannelli, Jeffrey Stevens, John S Kinsey, et al.
Energy & Fuels : an American Chemical Society Journal|April 25, 2020
Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine EngineRaju R Kumal, Jiawei Liu, Akshay Gharpure, et al.
Trials|December 6, 2017
PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trialSimon P Hammond, Jane L Cross, Lee Shepstone, et al.
JAMA Psychiatry|January 25, 2023
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 PandemicHao Luo, Wallis C Y Lau, Yi Chai, et al.
Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.
The Lancet. Psychiatry|June 9, 2018
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trialRobert Howard, Elizabeth Cort, Rosie Bradley, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Journal of the Air & Waste Management Association (1995)|May 24, 2012
Determination of the emissions from an aircraft auxiliary power unit (APU) during the Alternative Aviation Fuel Experiment (AAFEX)John S Kinsey, Michael T Timko, Scott C Herndon, et al.
Alzheimer'S Research & Therapy|September 12, 2024
TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trialYi Tang, Yi Xing, Liwei Sun, et al.
Age and Ageing|May 25, 2025
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort studyEdmund C L Cheung, Matthew Adesuyan, Máté Szilcz, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
Journal of Aerosol Science|May 16, 2024
Evaluation of methods for characterizing the fine particulate matter emissions from aircraft and other diffusion flame combustion aerosol sourcesRobert Giannelli, Jeffrey Stevens, John S Kinsey, et al.
Energy & Fuels : an American Chemical Society Journal|April 25, 2020
Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine EngineRaju R Kumal, Jiawei Liu, Akshay Gharpure, et al.
Trials|December 6, 2017
PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trialSimon P Hammond, Jane L Cross, Lee Shepstone, et al.
JAMA Psychiatry|January 25, 2023
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 PandemicHao Luo, Wallis C Y Lau, Yi Chai, et al.
Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.
The Lancet. Psychiatry|June 9, 2018
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trialRobert Howard, Elizabeth Cort, Rosie Bradley, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Journal of the Air & Waste Management Association (1995)|May 24, 2012
Determination of the emissions from an aircraft auxiliary power unit (APU) during the Alternative Aviation Fuel Experiment (AAFEX)John S Kinsey, Michael T Timko, Scott C Herndon, et al.
Alzheimer'S Research & Therapy|September 12, 2024
TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trialYi Tang, Yi Xing, Liwei Sun, et al.
Age and Ageing|May 25, 2025
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort studyEdmund C L Cheung, Matthew Adesuyan, Máté Szilcz, et al.
Pageof 27